Brind.

Citi initiated positive catalyst watch on Haemonetics and GE Healthcare in the MedTech sector.

2 reports, 1 independent Updated Jun 18
Gone quiet
Reports
2
Developments
3
Repetition
0%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Citi initiated positive catalyst watch on Haemonetics and GE Healthcare in the MedTech sector.

Who's involved

What this event is mainly about
GE HealthcareHaemonetics

How it developed

Newest first. Tap a step to see who reported it.
  1. Firms adjusted their stakes in Haemonetics stock, including raises, reductions, and lifts.1 source
  2. Financial analysts, including Needham & Company, Mizuho Financial Group, and Marie Thibault, questioned Haemonetics' long-term growth and product performance.Sub-event
  3. Citi upgraded outlook for Haemonetics and GE Healthcare in MedTech.

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped